Boston Trust Walden Corp has added 229,885 shares of $JAZZ to their portfolio, per a new SEC 13F filing. This disclosure reflects the funds' holdings for the 06-30-2025 report period. You can see the fund's full portfolio on Quiver Quantitative, and also track the largest institutional owners of $JAZZ.
JAZZ PHARMACEUTICALS PLC Hedge Fund Activity
We have seen 276 institutional investors add shares of JAZZ PHARMACEUTICALS PLC stock to their portfolio, and 233 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PACER ADVISORS, INC. removed 1,369,775 shares (-61.9%) from their portfolio in Q1 2025, for an estimated $170,057,566
- CAMBER CAPITAL MANAGEMENT LP removed 1,150,000 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $142,772,500
- VESTAL POINT CAPITAL, LP removed 975,000 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $121,046,250
- MILLENNIUM MANAGEMENT LLC removed 589,847 shares (-96.5%) from their portfolio in Q1 2025, for an estimated $73,229,505
- HOLOCENE ADVISORS, LP added 492,029 shares (+inf%) to their portfolio in Q1 2025, for an estimated $61,085,400
- DARWIN GLOBAL MANAGEMENT, LTD. removed 484,515 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $60,152,537
- BANK OF AMERICA CORP /DE/ added 402,189 shares (+68.0%) to their portfolio in Q1 2025, for an estimated $49,931,764
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
JAZZ PHARMACEUTICALS PLC Insider Trading Activity
JAZZ PHARMACEUTICALS PLC insiders have traded $JAZZ stock on the open market 21 times in the past 6 months. Of those trades, 4 have been purchases and 17 have been sales.
Here’s a breakdown of recent trading of $JAZZ stock by insiders over the last 6 months:
- SEAMUS MULLIGAN has made 4 purchases buying 101,621 shares for an estimated $9,993,081 and 0 sales.
- BRUCE C COZADD (Chairman & CEO) has made 0 purchases and 9 sales selling 13,000 shares for an estimated $1,699,645.
- ROBERT IANNONE (EVP, Global Head of R&D & CMO) has made 0 purchases and 3 sales selling 9,483 shares for an estimated $1,313,902.
- PATRICIA CARR (SVP, Chief Accounting Officer) has made 0 purchases and 4 sales selling 6,726 shares for an estimated $962,945.
- NEENA M PATIL (EVP & Chief Legal Officer) sold 3,800 shares for an estimated $550,506
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
JAZZ PHARMACEUTICALS PLC Analyst Ratings
Wall Street analysts have issued reports on $JAZZ in the last several months. We have seen 11 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Needham issued a "Buy" rating on 06/11/2025
- Baird issued a "Outperform" rating on 05/07/2025
- RBC Capital issued a "Outperform" rating on 05/07/2025
- Piper Sandler issued a "Overweight" rating on 05/07/2025
- Morgan Stanley issued a "Overweight" rating on 05/07/2025
- HC Wainwright & Co. issued a "Buy" rating on 03/10/2025
- UBS issued a "Buy" rating on 03/07/2025
To track analyst ratings and price targets for JAZZ PHARMACEUTICALS PLC, check out Quiver Quantitative's $JAZZ forecast page.
JAZZ PHARMACEUTICALS PLC Price Targets
Multiple analysts have issued price targets for $JAZZ recently. We have seen 12 analysts offer price targets for $JAZZ in the last 6 months, with a median target of $175.5.
Here are some recent targets:
- Jeffrey Hung from Morgan Stanley set a target price of $165.0 on 07/22/2025
- Ami Fadia from Needham set a target price of $202.0 on 06/11/2025
- Joel Beatty from Baird set a target price of $155.0 on 05/07/2025
- Gregory Renza from RBC Capital set a target price of $172.0 on 05/07/2025
- David Amsellem from Piper Sandler set a target price of $147.0 on 05/07/2025
- Oren Livnat from HC Wainwright & Co. set a target price of $217.0 on 03/10/2025
- Ashwani Verma from UBS set a target price of $179.0 on 03/07/2025
Note that there may be inaccuracies in these estimates due to filing errors by the funds, parsing errors by us, or other anomalies.
Check out Quiver Quantitative's $JAZZ ticker page for more data.
